CASR and kidney cancer: Furthermore, breast, prostate and kidney cancer cells often overexpress calcium-sensing receptors (CaSR), which promote migration toward Ca2+-rich tissues such as the bone as well the release of growth factors, proangiogenic factors, and chemokines that support proliferation and invasion of metastatic cells [34].